LONDON – On Wednesday, AstraZeneca (NASDAQ: AZN) said its China president Leon Wang had been detained by Chinese authorities and,
1 year ago
COPENHAGEN – Novo Nordisk (NYSE: NVO) is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States
On Tuesday, Novavax (NASDAQ: NVAX) said it has entered into a termination and settlement agreement with the UK Health Security
On Wednesday, Fresenius raised its full-year outlook after beating third-quarter expectations, citing strong performances at its Kabi and Helios divisions
COPENHAGEN – On Wednesday, Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug, reassuring investors worried that
LONDON – On Wednesday, Novo Nordisk (NYSE: NVO) chief financial officer Karsten Munk Knudsen said the company was aware of
On Tuesday, AstraZeneca shares recorded their worst day since March 2020 after a report that dozens of the drugmaker’s senior
On Monday, BioNTech (NASDAQ: BNTX), the German drugmaker, lowered its guidance for full-year revenue, citing COVID-19 uptake and price levels,
Americans are still eagerly seeking prescriptions for Eli Lilly’s (NYSE: LLY) and Novo Nordisk’s (NYSE: NVO) weight-loss and diabetes drugs
BRUSSELS/LONDON – EU antitrust regulators will decide by December 6 whether to clear Novo Holdings’ acquisition of contract drug manufacturer
ZURICH – Novartis (NYSE: NVS) expects to increase its annual sales by at least 5% per year in the coming
On Thursday, Smith & Nephew (NYSE: SNN), the British medical equipment maker, cut its annual underlying revenue growth forecast due
